No Data
Jasper Launches the Industry's First AI Knowledge Layer Built Specifically for Marketing
Stifel Maintains Jasper Therapeutics(JSPR.US) With Buy Rating, Maintains Target Price $80
RBC Capital Maintains Jasper Therapeutics(JSPR.US) With Buy Rating, Maintains Target Price $68
A Quick Look at Today's Ratings for Jasper Therapeutics(JSPR.US), With a Forecast Between $60 to $70
Jasper Therapeutics Advances in Antibody Therapy Development
Promising Outlook for Jasper Therapeutics: Buy Rating Reinforced by Advancements in Briquilimab
No Data
No Data
Kamacho09 OP : Shoulda bought more at 15